7FM-32199-26273
5 vaccinations
11 coded responses
65 check-ins
10 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 61-65
- ZIP prefix
- 970 / OR
- Registered
- 2021-03-04
- Relationship
- Self
- Race
- White
- Ethnicity
- N/A
Timeline
-
2021-03-04
Registered in v-safe
-
2021-03-04
Dose 1 — Moderna
- 2021-03-04
-
2021-03-05
Survey response — days 1–6 daily, dose 1MedDRA: Decreased appetite — Feeling: Good · Site: Pain · Joint pains, Fatigue or tirednessFree text: Decreased appetiteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-06
Survey response — days 1–6 daily, dose 1MedDRA: Feeling of body temperature change — Feeling: Good · Site: Pain, Swelling · FeverFree text: Temp was a degree above normal for me and during the nightMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-07
- 2021-03-08
- 2021-03-09
- 2021-03-10
-
2021-03-13
Health check-in — day 7, dose 1Feeling: Fair · Site: Redness, Swelling, Itching · Fatigue or tirednessAdult check-in
- 2021-03-18
- 2021-03-25
-
2021-04-01
Dose 2 — Moderna
- 2021-04-01
-
2021-04-02
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-04-03
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Swelling · Fever · Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-04-04
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness · Fatigue or tiredness, Nausea, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activitiesAdult check-in
- 2021-04-05
- 2021-04-06
- 2021-04-07
- 2021-04-08
- 2021-04-15
- 2021-04-22
-
2021-04-29
Survey response — day 28, dose 2MedDRA: Angina pectoris, Fatigue, Unevaluable event — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Symptoms: New angina and fatigue · Healthcare visit (other): Holter monitorMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-29
Report sent to call center — day 28, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-05-06
- 2021-05-13
-
2021-07-01
Survey response — 3 months, dose 2MedDRA: Hypothyroidism — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: HypothyroidismMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-07-01
Report sent to call center — 3 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-07-05
Call successfulDoes not wish to fill out VAERS report
-
2021-07-05
Call successfulDoes not wish to fill out VAERS report
- 2021-09-30
-
2021-11-26
Dose 3 — Moderna
-
2021-11-26
Health check-in — day 0, dose 3Feeling: Good · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-11-27
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2021-11-28
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fever · Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2021-11-29
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Fatigue or tiredness, NauseaAdult check-in
-
2021-11-30
Survey response — days 1–6 daily, dose 3MedDRA: Dizziness, Heart rate increased — Feeling: Fair · Fatigue or tiredness, NauseaFree text: Elevated heart rate with exercise caused lightheadedness and faint feelingsMedDRA releases: 2024-11 · check-in free text available
- 2021-12-01
- 2021-12-02
- 2021-12-03
- 2021-12-10
-
2021-12-17
Survey response — day 21, dose 3MedDRA: Fatigue, Increased upper airway secretion, Nasal congestion, Productive cough — Feeling: FairFree text: Nasal congestion, fatigue, mucus in back of throat that needs to be coughed up.MedDRA releases: 2024-11 · check-in free text available
- 2021-12-24
- 2021-12-31
- 2022-02-25
-
2022-05-10
Dose 4 — Moderna
-
2022-05-11
Health check-in — days 1–6 daily, dose 4Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2022-05-12
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2022-05-13
Survey response — days 1–6 daily, dose 4MedDRA: Tachycardia — Feeling: Fair · Site: Pain · Fatigue or tirednessFree text: Tachycardia with activityMedDRA releases: 2024-11 · check-in free text available
-
2022-05-14
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Headache, Fatigue or tiredness, Abdominal pain · Be unable to do your normal daily activitiesAdult check-in
- 2022-05-15
-
2022-05-16
Health check-in — days 1–6 daily, dose 4Feeling: Good · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2022-05-17
Survey response — day 7, dose 4MedDRA: Dyspnoea exertional, Tachycardia — Feeling: Fair · Fatigue or tirednessFree text: Tachycardia and SOB with activityMedDRA releases: 2024-11 · check-in free text available
- 2022-05-24
- 2022-05-31
- 2022-06-07
- 2022-06-14
- 2022-06-21
- 2022-08-09
-
2022-09-16
Dose 5 — ModernaCo-administered: Flu
-
2022-09-16
Survey response — day 0, dose 5MedDRA: Body temperature increased — Feeling: Good · Site: Pain · Headache, Fatigue or tirednessFree text: Low grade temperatureMedDRA releases: 2024-11 · check-in free text available
-
2022-09-17
Health check-in — days 1–6 daily, dose 5Feeling: Poor · Site: Pain · Fever · Headache, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2022-09-18
Health check-in — days 1–6 daily, dose 5Feeling: Fair · Site: Pain · Fever · Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2022-09-19
Health check-in — days 1–6 daily, dose 5Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2022-09-20
-
2022-09-21
Health check-in — days 1–6 daily, dose 5Feeling: Fair · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2022-09-22
- 2022-09-23
- 2022-09-30
- 2022-10-07
- 2022-10-14
- 2022-10-30
-
2022-12-16
Survey response — 3 months, dose 5MedDRA: Breast mass, Exposure to SARS-CoV-2, Quarantine, SARS-CoV-2 test negative — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Palpable 2-3 cm breast mass not called out on mammogram in June 2022. Also had a close contact exposure to Covid positive family member. I tested twice with home test and once with PCR and all were negative. Isolated for 10 days after exposureMedDRA releases: 2024-11 · check-in free text available
-
2022-12-16
Report sent to call center — 3 months, dose 5Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-12-20
Call successfulNot applicable - Accidental Reporting
-
2023-03-17
Survey response — 6 months, dose 5MedDRA: Chemotherapy, Pre-existing disease — Feeling: Poor · Be unable to do your normal daily activitiesMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-04 | Moderna | |
| 2 | 2021-04-01 | Moderna | |
| 3 | 2021-11-26 | Moderna | No |
| 4 | 2022-05-10 | Moderna | No |
| 5 | 2022-09-16 | Moderna | Flu |
Call center
3 call center cases
3 successful
Free text
Release 5 — days 1–6 daily, dose 1
Systemic reaction (other): Decreased appetite
Systemic reaction (other): Temp was a degree above normal for me and during the night
Release 8 — day 28, dose 2
Release 9 — 3 months, dose 2
Symptoms: Hypothyroidism
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Elevated heart rate with exercise caused lightheadedness and faint feelings
Release 10 — day 21, dose 3
Symptoms: Nasal congestion, fatigue, mucus in back of throat that needs to be coughed up.
Release 11 — days 1–6 daily, dose 4
Systemic reaction (other): Tachycardia with activity
Release 11 — day 7, dose 4
Systemic reaction (other): Tachycardia and SOB with activity
Release 12 — day 0, dose 5
Systemic reaction (other): Low grade temperature
Release 12 — 3 months, dose 5
Symptoms: Palpable 2-3 cm breast mass not called out on mammogram in June 2022. Also had a close contact exposure to Covid positive family member. I tested twice with home test and once with PCR and all were negative. Isolated for 10 days after exposure
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Unevaluable event | ✓ | ✓ | ✓ |
| SD | Angina pectoris | ✓ | ✓ | ✓ |
| SD | Breast mass | · | · | ✓ |
| SD | Chemotherapy | · | · | ✓ |
| SD | Exposure to SARS-CoV-2 | · | · | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Hypothyroidism | ✓ | ✓ | ✓ |
| SD | Increased upper airway secretion | · | · | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Productive cough | · | · | ✓ |
| SD | Quarantine | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SRO | Body temperature increased | · | · | ✓ |
| SRO | Decreased appetite | ✓ | ✓ | ✓ |
| SRO | Dizziness | · | · | ✓ |
| SRO | Dyspnoea exertional | · | · | ✓ |
| SRO | Feeling of body temperature change | ✓ | ✓ | ✓ |
| SRO | Heart rate increased | · | · | ✓ |
| SRO | Tachycardia | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release